Raymond James & Associates’s MiMedx Group MDXG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$84.2K Sell
14,242
-1,017
-7% -$6.01K ﹤0.01% 3757
2024
Q2
$106K Buy
15,259
+3,005
+25% +$20.8K ﹤0.01% 3686
2024
Q1
$94.4K Sell
12,254
-716
-6% -$5.51K ﹤0.01% 3703
2023
Q4
$114K Buy
+12,970
New +$114K ﹤0.01% 3599
2023
Q3
Sell
-51,314
Closed -$339K 3821
2023
Q2
$339K Sell
51,314
-4,100
-7% -$27.1K ﹤0.01% 3147
2023
Q1
$189K Hold
55,414
﹤0.01% 3473
2022
Q4
$154K Buy
55,414
+4,100
+8% +$11.4K ﹤0.01% 3500
2022
Q3
$147K Sell
51,314
-600
-1% -$1.72K ﹤0.01% 3499
2022
Q2
$180K Buy
51,914
+42
+0.1% +$146 ﹤0.01% 3511
2022
Q1
$244K Sell
51,872
-5,336
-9% -$25.1K ﹤0.01% 3521
2021
Q4
$346K Buy
57,208
+680
+1% +$4.11K ﹤0.01% 3341
2021
Q3
$343K Sell
56,528
-37,395
-40% -$227K ﹤0.01% 3302
2021
Q2
$1.18M Sell
93,923
-53,410
-36% -$668K ﹤0.01% 2474
2021
Q1
$1.52M Buy
147,333
+73,903
+101% +$761K ﹤0.01% 2209
2020
Q4
$667K Buy
+73,430
New +$667K ﹤0.01% 2598
2018
Q4
Sell
-161,109
Closed -$996K 3508
2018
Q3
$996K Sell
161,109
-4,400
-3% -$27.2K ﹤0.01% 2258
2018
Q2
$1.06M Buy
165,509
+3,991
+2% +$25.5K ﹤0.01% 2167
2018
Q1
$1.13M Sell
161,518
-17,284
-10% -$120K ﹤0.01% 2046
2017
Q4
$2.26M Sell
178,802
-33,966
-16% -$428K ﹤0.01% 1619
2017
Q3
$2.53M Buy
212,768
+35,860
+20% +$426K 0.01% 1481
2017
Q2
$2.65M Buy
176,908
+1,425
+0.8% +$21.3K 0.01% 1398
2017
Q1
$1.67M Buy
175,483
+175
+0.1% +$1.67K ﹤0.01% 1646
2016
Q4
$1.55M Sell
175,308
-9,100
-5% -$80.6K ﹤0.01% 1648
2016
Q3
$1.58M Buy
184,408
+2,300
+1% +$19.7K ﹤0.01% 1604
2016
Q2
$1.45M Sell
182,108
-10,800
-6% -$86.2K ﹤0.01% 1515
2016
Q1
$1.69M Buy
192,908
+30,700
+19% +$268K 0.01% 1373
2015
Q4
$1.52M Sell
162,208
-4,600
-3% -$43.1K 0.01% 1411
2015
Q3
$1.61M Buy
166,808
+47,250
+40% +$456K 0.01% 1335
2015
Q2
$1.39M Buy
119,558
+44,458
+59% +$515K 0.01% 1547
2015
Q1
$781K Buy
75,100
+52,100
+227% +$542K ﹤0.01% 1800
2014
Q4
$265K Buy
+23,000
New +$265K ﹤0.01% 2144